Work

Correction to: CD16xCD33 Bispecific Killer Cell Engager (BiKE) as potential immunotherapeutic in pediatric patients with AML and biphenotypic ALL

Year: 2021

Type: erratum

Source: Cancer Immunology Immunotherapy

DOI: 10.1007/s00262-021-03040-0

Authors: Sarah B. Reusing, Dan A. Vallera, Angela R. Manser, Titus Watrin, Sanil Bhatia, Martin Felices, Jeffrey S. Miller, Markus Uhrberg, Florian Babor

Institutions: Heinrich Heine University Düsseldorf, University of Minnesota, Masonic Cancer Center

Language: English

Topic: Immune Cell Function and Interaction

Subfield: Immunology

Field: Immunology and Microbiology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: hybrid

Estimated APC paid: $3,860

Funder: National Cancer Institute

Award: G1905428511

OpenAlex ID: W3202898050

Cites:

Cited by: 1

Related to: 10